These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 10148086)

  • 41. Implantation of transvenous nonthoracotomy cardioverter-defibrillator systems in patients with permanent endocardial pacemakers.
    Brooks R; Garan H; McGovern BA; Ruskin JN
    Am Heart J; 1995 Jan; 129(1):45-53. PubMed ID: 7817923
    [TBL] [Abstract][Full Text] [Related]  

  • 42. European Resuscitation Council Guidelines for Resuscitation 2010 Section 3. Electrical therapies: automated external defibrillators, defibrillation, cardioversion and pacing.
    Deakin CD; Nolan JP; Sunde K; Koster RW
    Resuscitation; 2010 Oct; 81(10):1293-304. PubMed ID: 20956050
    [No Abstract]   [Full Text] [Related]  

  • 43. Third generation antitachycardia pacing implantable cardioverter-defibrillators.
    Rasmussen MJ; Mangan DB
    Dimens Crit Care Nurs; 1994; 13(6):284-91. PubMed ID: 7729317
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Indications for dual-chamber (DDD) pacing in implantable cardioverter-defibrillator patients.
    Santini M; Ansalone G; Auriti A; Magris B; Pandozi C; Altamura G
    Am J Cardiol; 1996 Sep; 78(5A):116-8. PubMed ID: 8820847
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Implantable transvenous cardioverter-defibrillators.
    Bardy GH; Hofer B; Johnson G; Kudenchuk PJ; Poole JE; Dolack GL; Gleva M; Mitchell R; Kelso D
    Circulation; 1993 Apr; 87(4):1152-68. PubMed ID: 8462144
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of hyperkalaemia on cardiac rhythm devices.
    Barold SS; Herweg B
    Europace; 2014 Apr; 16(4):467-76. PubMed ID: 24465006
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A review of specialized and automated features in implantable cardiac devices.
    Ayinde H; Lloyd M
    J Cardiovasc Electrophysiol; 2020 Jan; 31(1):271-285. PubMed ID: 31724786
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Future of implantable electrical cardiac devices].
    Daubert JC; Behaghel A; Leclercq C; Mabo P
    Bull Acad Natl Med; 2014 Mar; 198(3):473-87; discussion 487-8. PubMed ID: 26427291
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Combined leadless pacemaker and subcutaneous implantable defibrillator therapy: feasibility, safety, and performance.
    Tjong FV; Brouwer TF; Smeding L; Kooiman KM; de Groot JR; Ligon D; Sanghera R; Schalij MJ; Wilde AA; Knops RE
    Europace; 2016 Nov; 18(11):1740-1747. PubMed ID: 26941338
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pacemakers and defibrillators: recent and ongoing studies that impact the elderly.
    Martinez C; Tzur A; Hrachian H; Zebede J; Lamas GA
    Am J Geriatr Cardiol; 2006; 15(2):82-7. PubMed ID: 16525220
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Combination use of an automatic anti-tachycardia pacemaker and an automatic implantable cardioverter-defibrillator in sustained recurrent ventricular tachycardia resistant to drugs].
    Benedini G; Caradonna E; Alfieri O; Visioli O
    G Ital Cardiol; 1989 Oct; 19(10):889-900. PubMed ID: 2612809
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Transvenous subcutaneous implantation technique of the cardioverter/defibrillator].
    Block M; Hammel D; Borggrefe M; Scheld HH; Breithardt G
    Herz; 1994 Oct; 19(5):259-77. PubMed ID: 8001899
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Initial experience with a new balloon-guided single lead catheter for internal cardioversion of atrial fibrillation and dual chamber pacing.
    Plewan A; Valina C; Herrmann R; Alt E
    Pacing Clin Electrophysiol; 1999 Jan; 22(1 Pt 2):228-32. PubMed ID: 9990636
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Survival in Women Versus Men Following Implantation of Pacemakers, Defibrillators, and Cardiac Resynchronization Therapy Devices in a Large, Nationwide Cohort.
    Varma N; Mittal S; Prillinger JB; Snell J; Dalal N; Piccini JP
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28490521
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Electrical therapy for cardiovascular emergencies.
    Ewy GA
    Circulation; 1986 Dec; 74(6 Pt 2):IV111-6. PubMed ID: 3536157
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Feasibility of concomitant implantation of permanent transvenous pacemaker and defibrillator systems.
    Blanck Z; Niazi I; Axtell K; Sra J; Jazayeri MR; Dhala A; Deshpande S; Akhtar M
    Am J Cardiol; 1994 Dec; 74(12):1249-53. PubMed ID: 7977099
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [From implantable cardioverter-defibrillator to cardiac resynchronization therapy with the use of epicardial left ventricular lead. The evolution of the treatment of post inflammatory heart failure--a case report].
    Gepner K; Sterliński M; Przybylski A; Maciag A; Kołsut P; Szwed H
    Kardiol Pol; 2006 Oct; 64(10):1113-7. PubMed ID: 17089244
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cardiovascular implantable electronic devices in athletes.
    Do R; Patton KK
    Cardiovasc Ther; 2010 Oct; 28(5):327-36. PubMed ID: 20553287
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A second defibrillator chest patch electrode will increase implantation rates for nonthoracotomy defibrillators.
    Solomon AJ; Swartz JF; Rodak DJ; Moore HJ; Hannan RL; Tracy CM; Fletcher RD
    Pacing Clin Electrophysiol; 1996 Sep; 19(9):1304-10. PubMed ID: 9005417
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Experience with a transvenous pacemaker-cardioconverter-defibrillator without subcutaneous patch].
    Gyöngy T; Merkely B; Tenczer J; Vecsey T; Horkay F; Kalmár I; Matkó I; Solti F; Bodor E
    Orv Hetil; 1995 Feb; 136(6):299-304. PubMed ID: 7885681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.